Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002396358 | SCV002671762 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-11-02 | criteria provided, single submitter | clinical testing | The c.764_776del13 pathogenic mutation, located in coding exon 4 of the MSH2 gene, results from a deletion of 13 nucleotides at nucleotide positions 764 to 776, causing a translational frameshift with a predicted alternate stop codon (p.S255Kfs*15). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |